Public company research profile

This public-disclosure research profile is not investment advice. It summarizes historical public filings, source links, confidence context, and hypothetical outcomes so readers can verify the evidence themselves.

Open in CopyWindow

Company research history

Tenet Healthcare Corporation Common Stock (THC)

Source-transparent disclosure history for this company, built from public CopyWindow signals and previous hypothetical outcomes.

9 disclosures
3 insiders
0 cluster signals
0.0% avg. 30d outcome

Company facts

Ticker / ISIN
THC / Not available
Exchange
Not available
Country
US
Sector
Not available

Disclosure history

Jonathan Jackson, Representative

sell disclosed on 27 May 2026 via House STOCK Act disclosures

Transaction value
Not available
Copy Window
Still fresh
Data Confidence
93%
Previous signal outcome
0.0%

Jonathan Jackson, Representative

sell disclosed on 27 May 2026 via House STOCK Act disclosures

Transaction value
1.001 US$
Copy Window
Still fresh
Data Confidence
93%
Previous signal outcome
0.0%

Jonathan Jackson, Representative

sell disclosed on 12 Mar 2026 via House STOCK Act disclosures

Transaction value
1.001 US$
Copy Window
Probably too late
Data Confidence
93%
Previous signal outcome
0.0%

Jonathan Jackson, Representative

buy disclosed on 8 Jan 2026 via House STOCK Act disclosures

Transaction value
Not available
Copy Window
Probably too late
Data Confidence
93%
Previous signal outcome
0.0%

Jonathan Jackson, Representative

buy disclosed on 15 Oct 2025 via House STOCK Act disclosures

Transaction value
1.001 US$
Copy Window
Probably too late
Data Confidence
93%
Previous signal outcome
0.0%

Lisa McClain, Representative

sell disclosed on 12 Sept 2025 via House STOCK Act disclosures

Transaction value
1.001 US$
Copy Window
Probably too late
Data Confidence
93%
Previous signal outcome
0.0%

Lisa McClain, Representative

buy disclosed on 13 Aug 2025 via House STOCK Act disclosures

Transaction value
1.001 US$
Copy Window
Probably too late
Data Confidence
93%
Previous signal outcome
0.0%

John James, Representative

sell disclosed on 6 Sept 2024 via House STOCK Act disclosures

Transaction value
1.001 US$
Copy Window
Probably too late
Data Confidence
93%
Previous signal outcome
0.0%

John James, Representative

buy disclosed on 2 Sept 2024 via House STOCK Act disclosures

Transaction value
1.001 US$
Copy Window
Probably too late
Data Confidence
93%
Previous signal outcome
0.0%